TScan Therapeutics Inc (TCRX)
1.21
-0.06
(-4.72%)
USD |
NASDAQ |
Apr 03, 16:00
1.27
+0.06
(+4.96%)
After-Hours: 20:00
TScan Therapeutics Profit Margin (Quarterly): -5.38K% for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Voyager Therapeutics Inc | -549.3% |
| Mersana Therapeutics Inc | -86.28% |
| Sutro Biopharma Inc | -489.2% |
| Larimar Therapeutics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -63.81% |
| Return on Assets | -39.67% |
| Return on Invested Capital | -55.31% |
| Operating Margin (Quarterly) | -5.52K% |
| Return on Net Operating Assets | -183.2% |